$LCII
LCI INDUSTRIES

2023 Q2 Form 10-Q Financial Statement

#000076374423000040 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $1.015B $973.3M
YoY Change -33.95% -40.82%
Cost Of Revenue $796.5M $787.2M
YoY Change -29.33% -33.3%
Gross Profit $218.1M $186.1M
YoY Change -46.68% -59.92%
Gross Profit Margin 21.5% 19.12%
Selling, General & Admin $162.9M $166.0M
YoY Change -14.37% -14.66%
% of Gross Profit 74.7% 89.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $33.05M $32.50M
YoY Change 3.58% 2.16%
% of Gross Profit 15.15% 17.47%
Operating Expenses $162.9M $166.0M
YoY Change -14.37% -14.66%
Operating Profit $55.17M $20.04M
YoY Change -74.78% -92.57%
Interest Expense -$10.25M -$10.39M
YoY Change 65.55% 66.25%
% of Operating Profit -18.58% -51.86%
Other Income/Expense, Net
YoY Change
Pretax Income $44.93M $9.649M
YoY Change -78.87% -96.34%
Income Tax $11.50M $2.390M
% Of Pretax Income 25.6% 24.77%
Net Earnings $33.43M $7.259M
YoY Change -78.37% -96.3%
Net Earnings / Revenue 3.29% 0.75%
Basic Earnings Per Share $1.32 $0.29
Diluted Earnings Per Share $1.31 $0.29
COMMON SHARES
Basic Shares Outstanding 25.30M shares 25.18M shares
Diluted Shares Outstanding 25.44M shares 25.29M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $22.09M $23.47M
YoY Change -59.82% -57.68%
Cash & Equivalents $22.09M $23.47M
Short-Term Investments
Other Short-Term Assets $83.66M $91.62M
YoY Change 18.65% 29.47%
Inventory $830.0M $909.4M
Prepaid Expenses
Receivables $299.5M $340.3M
Other Receivables $0.00 $0.00
Total Short-Term Assets $1.235B $1.365B
YoY Change -27.24% -25.3%
LONG-TERM ASSETS
Property, Plant & Equipment $478.9M $480.9M
YoY Change 4.9% 6.84%
Goodwill $584.3M $566.2M
YoY Change 5.31% 0.74%
Intangibles $477.3M $491.4M
YoY Change -6.91% -8.83%
Long-Term Investments
YoY Change
Other Assets $59.50M $57.52M
YoY Change 3.17% -8.29%
Total Long-Term Assets $1.841B $1.845B
YoY Change 3.15% 1.71%
TOTAL ASSETS
Total Short-Term Assets $1.235B $1.365B
Total Long-Term Assets $1.841B $1.845B
Total Assets $3.076B $3.209B
YoY Change -11.67% -11.85%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $182.6M $169.9M
YoY Change -36.51% -50.17%
Accrued Expenses $196.1M $205.2M
YoY Change -33.62% -40.61%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $27.71M $25.45M
YoY Change 32.09% 20.57%
Total Short-Term Liabilities $441.5M $436.0M
YoY Change -30.83% -41.16%
LONG-TERM LIABILITIES
Long-Term Debt $915.8M $1.056B
YoY Change -16.88% -16.58%
Other Long-Term Liabilities $103.4M $102.3M
YoY Change -26.18% -35.05%
Total Long-Term Liabilities $1.019B $1.158B
YoY Change -17.93% -18.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $441.5M $436.0M
Total Long-Term Liabilities $1.019B $1.158B
Total Liabilities $1.706B $1.850B
YoY Change -18.33% -22.32%
SHAREHOLDERS EQUITY
Retained Earnings $1.208B $1.201B
YoY Change -1.9% 8.85%
Common Stock $235.8M $231.6M
YoY Change 5.02% 6.68%
Preferred Stock
YoY Change
Treasury Stock (at cost) $82.22M $82.22M
YoY Change 41.36% 41.36%
Treasury Stock Shares 3.341M shares
Shareholders Equity $1.371B $1.360B
YoY Change
Total Liabilities & Shareholders Equity $3.076B $3.209B
YoY Change -11.67% -11.85%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $33.43M $7.259M
YoY Change -78.37% -96.3%
Depreciation, Depletion And Amortization $33.05M $32.50M
YoY Change 3.58% 2.16%
Cash From Operating Activities $198.9M $74.68M
YoY Change -6.64% -44.65%
INVESTING ACTIVITIES
Capital Expenditures $16.92M $17.16M
YoY Change -158.76% -59.18%
Acquisitions $6.250M
YoY Change -87.52%
Other Investing Activities -$17.22M -$1.960M
YoY Change -2481.33% -994.98%
Cash From Investing Activities -$34.14M -$21.45M
YoY Change 21.59% -76.77%
FINANCING ACTIVITIES
Cash Dividend Paid $26.56M
YoY Change 16.15%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -166.5M -$76.82M
YoY Change -10.04% 55.78%
NET CHANGE
Cash From Operating Activities 198.9M $74.68M
Cash From Investing Activities -34.14M -$21.45M
Cash From Financing Activities -166.5M -$76.82M
Net Change In Cash -1.746M -$24.03M
YoY Change 1547.17% 222.73%
FREE CASH FLOW
Cash From Operating Activities $198.9M $74.68M
Capital Expenditures $16.92M $17.16M
Free Cash Flow $182.0M $57.52M
YoY Change -24.76% -38.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000763744
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-13646
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
LCI INDUSTRIES
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3250533
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3501 County Road 6 East
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
46514
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Elkhart,
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IN
CY2023Q1 dei City Area Code
CityAreaCode
574
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
535-1125
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, $.01 par value
CY2023Q1 dei Trading Symbol
TradingSymbol
LCII
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25298420 shares
CY2023Q1 us-gaap Revenues
Revenues
973310000 usd
CY2022Q1 us-gaap Revenues
Revenues
1644568000 usd
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
787239000 usd
CY2022Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1180325000 usd
CY2023Q1 us-gaap Gross Profit
GrossProfit
186071000 usd
CY2022Q1 us-gaap Gross Profit
GrossProfit
464243000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
166028000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
194542000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
20043000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
269701000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-10394000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-6252000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
9649000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
263449000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2390000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
67268000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
7259000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
7.75
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
7.71
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25228000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25329000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25293000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25461000 shares
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
7259000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
196181000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2000000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2882000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
9259000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
193299000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
23465000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47499000 usd
CY2023Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7645000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5904000 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
340305000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
214262000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
909385000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1029705000 usd
CY2023Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
91624000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
99310000 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
1364779000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
1390776000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
480904000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
482185000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
566178000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
567063000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
491415000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
503320000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
248575000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
247007000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
57516000 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
56561000 usd
CY2023Q1 us-gaap Assets
Assets
3209367000 usd
CY2022Q4 us-gaap Assets
Assets
3246912000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
25450000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
23086000 usd
CY2023Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
169883000 usd
CY2022Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
143529000 usd
CY2023Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
35516000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
35447000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
205182000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
219238000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
436031000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
421300000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1055625000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1095888000 usd
CY2023Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
224451000 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
222478000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
31405000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
30580000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
102344000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
95658000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1849856000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1865904000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
286000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
285000 usd
CY2023Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
231294000 usd
CY2022Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
234956000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1201443000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
1221279000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
8704000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6704000 usd
CY2023Q1 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
1441727000 usd
CY2022Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
1463224000 usd
CY2023Q1 us-gaap Treasury Stock Value
TreasuryStockValue
82216000 usd
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
82216000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1359511000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1381008000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3209367000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3246912000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
7259000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
196181000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32499000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31812000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
4695000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
6517000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-877000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1771000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
123072000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
240404000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-131708000 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
31278000 usd
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5577000 usd
CY2022Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-20495000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
25822000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
57808000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-10689000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
92024000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
74676000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
134926000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17159000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
42037000 usd
CY2023Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
6250000 usd
CY2022Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
50089000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-1960000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
219000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21449000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-92345000 usd
CY2023Q1 lcii Proceedsfrom Issuanceof Sharesunder Incentiveand Sharebased Compensation Plans Including Stock Options Netof Payments Relatedto Tax Withholdingfor Sharebased Compensation
ProceedsfromIssuanceofSharesunderIncentiveandSharebasedCompensationPlansIncludingStockOptionsNetofPaymentsRelatedtoTaxWithholdingforSharebasedCompensation
-8888000 usd
CY2022Q1 lcii Proceedsfrom Issuanceof Sharesunder Incentiveand Sharebased Compensation Plans Including Stock Options Netof Payments Relatedto Tax Withholdingfor Sharebased Compensation
ProceedsfromIssuanceofSharesunderIncentiveandSharebasedCompensationPlansIncludingStockOptionsNetofPaymentsRelatedtoTaxWithholdingforSharebasedCompensation
-10569000 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
165300000 usd
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
372400000 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
201385000 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
330600000 usd
CY2023Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
5276000 usd
CY2022Q1 us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
55642000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
26563000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
22870000 usd
CY2023Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
CY2022Q1 us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
2031000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-12000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-4000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-76824000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-49316000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-437000 usd
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-712000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-24034000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-7447000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
47499000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
62896000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
23465000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
55449000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
9052000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
3943000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
390000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
192000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2304000 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
2400000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1092875000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
196181000 usd
CY2022Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
138208 shares
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-10569000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6517000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2882000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.9
CY2022Q1 us-gaap Dividends Cash
DividendsCash
22870000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
1259252000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1381008000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
7259000 usd
CY2023Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
119091 shares
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-8888000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4695000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2000000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2023Q1 us-gaap Dividends Cash
DividendsCash
26563000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
0 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1359511000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Use of Estimates</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, net sales and expenses, and related disclosure of contingent assets and liabilities. On an ongoing basis, the Company evaluates its estimates, including, but not limited to, those related to product returns, sales and purchase rebates, accounts receivable, inventories, goodwill and other intangible assets, net assets of acquired businesses, income taxes, warranty and product recall obligations, self-insurance obligations, operating lease right-of-use assets and obligations, asset retirement obligations, long-lived assets, pension and post-retirement benefits, stock-based compensation, segment allocations, contingent consideration, environmental liabilities, contingencies, and litigation. The Company bases its estimates on historical experience, other available information, and various other assumptions believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities not readily apparent from other resources. Actual results and events could differ significantly from management estimates.</span></div>
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25228000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25329000 shares
CY2023Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
65000 shares
CY2022Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
132000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25293000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25461000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
160000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
111000 shares
CY2021Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
2800000 shares
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
259.84
CY2021Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
259.84
CY2021Q2 us-gaap Payments For Hedge Financing Activities
PaymentsForHedgeFinancingActivities
100100000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
567063000 usd
CY2023Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
4181000 usd
CY2023Q1 us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
-7414000 usd
CY2023Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
2348000 usd
CY2023Q1 us-gaap Goodwill
Goodwill
566178000 usd
CY2023Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
760861000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
269446000 usd
CY2023Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
491415000 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
759043000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
255723000 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
503320000 usd
CY2023Q1 us-gaap Inventory Raw Materials
InventoryRawMaterials
529497000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
600601000 usd
CY2023Q1 us-gaap Inventory Work In Process
InventoryWorkInProcess
46951000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
44850000 usd
CY2023Q1 us-gaap Inventory Finished Goods
InventoryFinishedGoods
332937000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
384254000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
909385000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
1029705000 usd
CY2023Q1 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
55800000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
55900000 usd
CY2023Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
959897000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
945255000 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
478993000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
463070000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
480904000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
482185000 usd
CY2023Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
57148000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
77804000 usd
CY2023Q1 lcii Business Combination Deferred Acquisition Payments And Contingent Consideration Liability Current
BusinessCombinationDeferredAcquisitionPaymentsAndContingentConsiderationLiabilityCurrent
34086000 usd
CY2022Q4 lcii Business Combination Deferred Acquisition Payments And Contingent Consideration Liability Current
BusinessCombinationDeferredAcquisitionPaymentsAndContingentConsiderationLiabilityCurrent
34013000 usd
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
40358000 usd
CY2022Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
35148000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
73590000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
72273000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
205182000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
219238000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
54528000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
52114000 usd
CY2023Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
20827000 usd
CY2022Q1 us-gaap Product Warranty Expense
ProductWarrantyExpense
15441000 usd
CY2023Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
15227000 usd
CY2022Q1 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
8770000 usd
CY2023Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
60128000 usd
CY2022Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
58785000 usd
CY2023Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
19770000 usd
CY2022Q1 us-gaap Product Warranty Accrual Noncurrent
ProductWarrantyAccrualNoncurrent
20530000 usd
CY2023Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
40358000 usd
CY2022Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
38255000 usd
CY2023Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
8332000 usd
CY2022Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
9052000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
1081075000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
1118974000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
25450000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
23086000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1055625000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1095888000 usd
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
15244000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
12912000 usd
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1480000 usd
CY2022Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1840000 usd
CY2023Q1 us-gaap Variable Lease Cost
VariableLeaseCost
1000000 usd
CY2022Q1 us-gaap Variable Lease Cost
VariableLeaseCost
713000 usd
CY2023Q1 us-gaap Lease Cost
LeaseCost
17724000 usd
CY2022Q1 us-gaap Lease Cost
LeaseCost
15465000 usd
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
75000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28639000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
28519000 shares
CY2023Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
3341000 shares
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
3341000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25298000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25178000 shares
CY2022Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.90
CY2022Q2 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2022Q3 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2022Q4 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
4.05
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
1.05
CY2022Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
200000000 shares
CY2022Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P3Y
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
253490 shares
CY2022 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
94.89
CY2022 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
24100000 usd
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q1 us-gaap Revenues
Revenues
973310000 usd
CY2022Q1 us-gaap Revenues
Revenues
1644568000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
20043000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
269701000 usd
CY2023Q1 us-gaap Revenues
Revenues
973310000 usd
CY2022Q1 us-gaap Revenues
Revenues
1644568000 usd

Files In Submission

Name View Source Status
lcii-20230331_lab.xml Edgar Link unprocessable
0000763744-23-000040-index-headers.html Edgar Link pending
0000763744-23-000040-index.html Edgar Link pending
0000763744-23-000040.txt Edgar Link pending
0000763744-23-000040-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lcii-03312023xex311.htm Edgar Link pending
lcii-03312023xex312.htm Edgar Link pending
lcii-03312023xex32.htm Edgar Link pending
lcii-03312023xex321.htm Edgar Link pending
lcii-03312023xex322.htm Edgar Link pending
lcii-20230331.htm Edgar Link pending
lcii-20230331.xsd Edgar Link pending
lcii-20230331_g1.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lcii-20230331_cal.xml Edgar Link unprocessable
lcii-20230331_def.xml Edgar Link unprocessable
lcii-20230331_pre.xml Edgar Link unprocessable
lcii-20230331_htm.xml Edgar Link completed
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending